Citius Oncology, Inc. CTOR
0.50 USD -0.06 (-10.95%)
Regular-session close
0.50 0.00 0.00%
After hours · Nov 20, 4:00 PM ET
0.502 Day range 0.5698
0.491 52-week range 1.83
- YTD
- -49.65%
- 1 year
- -55.44%
News
benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers Senti Biosciences (NASDAQ:SNTI) stock rose 51.8% to $0.27 during Monday's after-market session. The company's market cap stands at $5.9 million. Polyrizon (NASDAQ:PLRZ) shares increased by…benzinga.com Citius Oncology Reports Preliminary Q4 FY2026 LYMPHIR Wholesaler Unit Sales More Than Doubling 120% To 792 Units, With 950 Institutional Vial Orders And 54 Institutions Ordering The CTCL Treatment itius Oncology, Inc. ("Citius Oncology" or the "Company") (NASDAQ:CTOR), an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius
